SCHEDULE 13D/A: Hestia Capital Affiliates Update Pitney Bowes Stake and Board Representation

Sentiment:

Beneficial Ownership Update


Hestia Capital and its affiliates have updated their beneficial ownership in Pitney Bowes Inc., confirming a new director appointment to the board as per a prior cooperation agreement.

Summary

  • Hestia Capital Management, LLC and its affiliates, including Hestia Capital Partners LP and Helios I, LP, collectively beneficially own 12,035,045 shares of Pitney Bowes Inc., representing approximately 6.6% of the outstanding common stock.
  • Kurtis J. Wolf, managing member of Hestia Capital Management, LLC, directly owns 35,280 shares and beneficially owns a total of 12,070,325 shares, representing approximately 6.7% of the outstanding common stock.
  • The aggregate beneficial ownership percentages are based on 181,253,371 shares outstanding as of April 30, 2025.
  • The shares were primarily purchased with working capital, including potential margin loans.
  • The aggregate purchase price for shares directly owned by Hestia Capital was approximately $18,853,829 for 4,810,917 shares.
  • The aggregate purchase price for shares directly owned by Helios was approximately $21,292,339 for 6,639,492 shares.
  • The aggregate purchase price for shares held in Separately Managed Accounts (SMAs) was approximately $2,323,581 for 584,636 shares.
  • On June 17, 2025, Pitney Bowes announced the appointment of Brent Rosenthal as a director to its Board, effective June 16, 2025.
  • Mr. Rosenthal's appointment was made pursuant to Section 1(c) of the cooperation agreement dated January 31, 2024, between Pitney Bowes and the Reporting Persons, replacing Lance Rosenzweig as a Replacement Director.
  • On May 27, 2025, Mr. Wolf received 23,810 shares upon the vesting of restricted stock units, with 7,434 shares withheld for taxes.
  • On June 16, 2025, Helios I, LP made an in-kind distribution of 1,670,000 shares to certain limited partners for no consideration.

Sentiment

Score: 6

Explanation: The filing indicates the continued implementation of a cooperation agreement with a significant activist investor, which can be viewed as a positive step towards agreed-upon governance and strategic alignment. The changes in ownership are largely administrative or pre-planned, not signaling new negative developments.

Positives

  • The appointment of Brent Rosenthal to the Board of Directors aligns with the previously established cooperation agreement, indicating continued collaboration between the company and its significant shareholders.
  • The structured replacement of a director (Lance Rosenzweig by Brent Rosenthal) under a cooperation agreement suggests an orderly transition and adherence to agreed-upon governance terms.

Negatives

  • Helios I, LP's in-kind distribution of 1,670,000 shares to limited partners, while for no consideration, reduces the direct shareholding of Helios, potentially diluting its direct voting power, though overall beneficial ownership through Hestia entities remains substantial.

Risks

  • The filing includes a standard disclaimer that the Reporting Persons do not admit to beneficial ownership of securities they do not directly own, which is a common legal protection in Schedule 13D filings.

Future Outlook

The document does not contain explicit forward-looking statements or guidance regarding the company's future financial performance or strategic direction beyond the implementation of the cooperation agreement.

Industry Context

This filing primarily concerns changes in beneficial ownership and corporate governance at Pitney Bowes Inc., specifically the ongoing influence of activist investor Hestia Capital. It reflects a continuation of previously agreed-upon terms, rather than a new industry-wide trend or competitive development. The appointment of a director by an activist investor is a common occurrence in situations where shareholders seek to influence corporate strategy or performance.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorLance RosenzweigBrent RosenthalJune 16, 2025Appointment pursuant to Section 1(c) of the cooperation agreement dated January 31, 2024, replacing Lance Rosenzweig as a Replacement Director.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionAppointment of Brent Rosenthal as a director to the Board of Directors, effective June 16, 2025, replacing Lance Rosenzweig. This change is in accordance with the cooperation agreement between the Issuer and the Reporting Persons.June 16, 2025Reinforces the terms of the existing cooperation agreement, potentially leading to greater alignment between the activist investor's interests and the company's strategic direction.

Stakeholder Impact

  • Shareholders: The change in board composition and the updated beneficial ownership percentages directly impact shareholders by altering the governance structure and the influence of a significant investor group. The in-kind distribution by Helios affects its limited partners.
  • Board of Directors: The board gains a new member, Brent Rosenthal, who is aligned with the activist investor group, potentially influencing future strategic decisions and oversight.

Next Steps

  • Brent Rosenthal will serve as a director on the Board of Directors of Pitney Bowes Inc. following his effective appointment on June 16, 2025.

Key Dates

DateDescription
January 31, 2024Date of the Cooperation Agreement between Pitney Bowes Inc. and the Reporting Persons.
April 30, 2025Date as of which 181,253,371 shares of Pitney Bowes Inc. common stock were reported outstanding in the Issuer's Form 10-Q.
May 8, 2025Date Pitney Bowes Inc. filed its Quarterly Report on Form 10-Q with the SEC.
May 27, 2025Kurtis J. Wolf received 23,810 shares upon vesting of restricted stock units.
June 16, 2025Effective date of Brent Rosenthal's appointment as a director to the Board of Directors; Helios I, LP made an in-kind distribution of 1,670,000 shares to limited partners.
June 17, 2025Pitney Bowes Inc. announced the appointment of Brent Rosenthal as a director.
June 18, 2025Date of filing of this Schedule 13D Amendment No. 10.

Recommendation

hold

Keywords

Pitney Bowes, Hestia Capital, Beneficial Ownership, Board of Directors, Corporate Governance, Activist Investor, SEC Filing, Schedule 13D, Common Stock, Director Appointment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.